Very helpful overview of the current landscape 🎀 #Her2 #breastcancer

Very proud of our own Fawzi Abu Rous, MD representing Henry Ford Health at the #EGFRSummit22 ⭐️💫

🌟Our program is thrilled to welcome our six amazing new fellows in 2023! 🌟Congrats to all who matched into their subspecialties of choice today! Henry Ford Health Fawzi Abu Rous, MD Sowjanya Vuyyala Rebecca Chacko Hussna E. Abunafeesa Rayli Pichardo MD Aula Ramo #MatchDay2022 #hemeonc #onctok

Day 1 #SABCS2022 Highlights #CommunityOncology 1. Racial Disparities Touch, The Black Breast Cancer Alliance ™️ Yara Abdou, MD, MSCR 2. Role of Palliative care Tara Kaufmann MD MSCE 3. NeoAdj Endocrine Rx in early #breastcancer 4. Contralat mastectomy w/mBRCA #bcsm SABCS #MedTwitter OncoAlert Integrity CE SoMe CME 1/11

📢 Huge shout out to the amazing Delta crew (DTW>SAT) who found my runaway AirPod that slipped through the cracks 🥹. You guys are amazing! 🎉 🤍

Excited to attend my very first #SABCS! 🌟🤩 #BreastCancer #AACR

✅ Poster presentation on our retrospective study looking at how BCI is incorporated into decision on extended endo tx. Punch line: Clinical decisions are concordant with #BCI results, it’s a useful clinical tool in this setting 💫 📝 #sabcs #henryfordhealth Henry Ford Hematology/Oncology Fellowship

Neoadjuvant TDXd in Her2 low #breastcancer response rate 68% - interesting and important data, when TDXd is trials are moving into adjuvant Her2 low #breastcancer OncoAlert SABCS #SABCS22

Congratulations to our stellar 3rd year fellow Hussna E. Abunafeesa on presenting her research at #SABCS22 #bcsm #OncTwitter #MedTwitter #cardioonc

What to do when the dx looks like a duck, walks like a duck, quacks like a duck, responds to PLEX like a duck…but then ADAMTS13 is normal? 🤔🤦🏽‍♀️🩸@AaronGoodman33 #hemetwitter #hoctrainee #MedTwitter #onctwitter

Important study: DESTINY-Breast09 looking at TDXd +/- pertuzumab vs THP for 1L therapy of HER2+ MBC; currently enrolling

🌟 Our superstar chief fellow, Fawzi Abu Rous, MD, has been repping us strong at #TTLC23, including a poster presentation highlighting the prognostic utility of 3q amp in SqCC #NSCLC! 🧬🔬 #medtok #onctok #lungcancer #hemonctrainee Henry Ford Health

🚨Our paper "Prognostic relevance of 3q amplification in squamous cell carcinoma of the lung" is finally online on JTO & JTO CRR! I'm grateful for Shirish Gadgeel & NALLASIVAM PALANISAMY for mentoring me on this project! Huge thanks to our⭐️team 🔗jtocrr.org/article/S2666-… Tweetorial👇

Truly inspiring reminder of all the work that has been done and all that is to come in oncology 💫 #medtok #onctok #OncTwitter

🔔🌟Shout out & congratulations to our rising chiefs: Zaid Alsaheli & Aula Ramo! 💥 We’re very excited for all that is to come in 2023-24! Henry Ford Health Hem-Onc Fellows Network #OncTwitter #HOFellows

No better Monday midday pick-me-up than a visit from the Detroit Symphony at the Henry Ford Health Cancer Pavilion 🎶 ☀️ #IAmHenry

Oh what a night Henry Ford Health Alumni Dinner! Both 3rd year fellows William P. Dillon, D.O. & Seema Joshi were nominated for 2 prestigious awards alongside amazing candidates: excellence in teaching & overall (respectively). We’re so proud of them both!!!

Congratulations to Seema Joshi who took home the Roger F Smith Outstanding Fellow Award. For 4 years in a row, one of our ID fellows has taken this home! It’s amazing to see them recognized on a system scale. Congratulations to both!

💫 Congrats to Fawzi Abu Rous, MD!! We are truly bursting with excitement over this accomplishment and could not be more proud! 🏆 🎖️

Bottom line from #ASCO23 for BC: can give cdk46 as second line in the lower risk patients; fixed lower dose cape as good and less toxic; adjuvant ribo shows early benefit; ofs in younger patients shows benefit; it’s time to do smaller bio marker trials like #phergain. #bcsm